The treatment of salmonellosis with trimethoprim-sulphamethoxazole and their combination with polymyxin B in adult patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004342:Drug Hypersensitivity; D005243:Feces / Q000382:microbiology; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011113:Polymyxins / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012475:Salmonella / Q000187:drug effects; D012480:Salmonella Infections / Q000097:blood / Q000188:drug therapy* / Q000382:microbiology; D012703:Serotyping; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011113:Polymyxins; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole